Radiation oncology and interventional cardiology firm Implant Sciences has initiated a direct marketing and sales program to sell its I-Plant brachytherapy seeds for use in the treatment of prostate cancer, according to the Wakefield, MA-based company.
In conjunction with the direct sales program, the developer has entered into an agreement with Med-Tec, its current distributor of the I-Plant product. Med-Tec has agreed to transition its customers and marketing materials for a payment of approximately $39,000 per month over the next 29 months, beginning in September, Implant Sciences said.
By AuntMinnie.com staff writersAugust 7, 2003
Related Reading
Implant Sciences lands NCI development grant, April 25, 2003
Implant Sciences gets NIH grant, April 17, 2003
Implant Sciences gets CE Mark for I-125 brachytherapy seeds, August 2, 2001
Copyright © 2003 AuntMinnie.com
